Role of Psychedelics in Treatment-Resistant Depression.
The Psychiatric clinics of North America June 1, 2023 Shubham Kamal, Manish Kumar Jha, Rajiv Radhakrishnan 32 citations
There is increasing interest in exploring the therapeutic potential of psychedelics in treatment-resistant depression (TRD). Classic psychedelics (such as psilocybin, LSD, ayahuasca/DMT), and atypical psychedelics (such as ketamine) have been studied in TRD. The evidence for the classic psychedelics TRD is limited at the present time; early studies however show promising results. There is also...